| | 60643-86-9 Basic information More.. |
| Product Name: | VIGABATRIN | | Synonyms: | [R,S]-4-AMINO-5-HEXENOIC ACID;VIGABATRIN;4-amino-5-hexenoicaci;4-amino-5-hexenoicacid;mdl71754;rmi71754;sabril;CPP109, CPP-109, CPP 109, RMI 71754, RMI71754, RMI-71754, MDL 71754, MDL-71754, MDL71754, VIGABATRIN, GAMMA-VINYL-GABA, SABRIL, SABRILEX | | CAS: | 60643-86-9 | | MF: | C6H11NO2 | | MW: | 129.16 | | EINECS: | 637-414-1 | | Mol File: | 60643-86-9.mol |  |
Use
Hepatic impairment
No dose adjustment is required for patients with hepatic impairment.
Renal impairment
Consider reducing maintenance dose or frequency of administration.
Pregnancy
Based on data on pregnancies exposed to vigabatrin, no definite conclusion can be drawn as to whether vigabatrin produces an increased risk of malformation when taken during pregnancy because of limited data and the administration of concomitant AEDs.
Vigabatrin should not be used during pregnancy unless it is required based on the clinical condition of the patient. In such cases, the dose of vigabatrin should be monitored carefully during pregnancy and after birth, and adjustments made on a clinical basis.
Vigabatrin is excreted in human milk: since there is insufficient information on the effects of vigabatrin in newborns/ infants, the possibility of avoiding breast- feeding should be considered.
- Vigabatrin
-
- 2025-08-20
- CAS:60643-86-9
- Min. Order:
- Purity: 0.99
- Supply Ability:
- VIGABATRIN
-
- US $0.00-0.00 / kg
- 2025-08-20
- CAS:60643-86-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000
- Vigabatrin
-
- US $44.00-128.00 / mg
- 2025-07-29
- CAS:60643-86-9
- Min. Order:
- Purity: 99.88%
- Supply Ability: 10g
|
|
60643-86-9
Recommend Suppliers |
|